China Research & Intelligence, March 2012, Pages: 60
Research Report on Chinese Bio-PharmaceuticalIndustry, 2012 "In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including
Global Industry Analysts, Inc., Jan 2012, Pages: 443
the pharmaceutical market outlook across various markets worldwide. Regional markets extensively discussed in the report include the United States, Canada, Japan, China, Germany, South Korea and India, among several
Digital Vector, Aug 2005, Pages: 360
to invest in this segment of the market.
This report looks at the following topics in relation to the ChinesePharmaceuticalIndustry:
- Industry Overview
- Key Trends
- Industry in Transition
- Government
CCM International Limited, May 2011, Pages: 288
development. In the last two decades, WB industry in China has developed at a rapid clip.
The first version and the second version of this report had been finished in April 2008 and by February 2009. The third
Global Industry Analysts, Inc., Oct 2010, Pages: 767
Netwrok Receive FDA Approval 26
9. RECENT INDUSTRY ACTIVITY 27
China Life Insurance Inks Agreement with Sino Biopharmaceutical 27
Azur
Research In China, Jan 2007, Pages: 110
become the development mode of pharmaceuticalindustry.
Please note this report is currently only available in Chinese. However, if you wish to obtain an English version, a translation service
Global Industry Analysts, Inc., Jan 2011, Pages: 255
.
Asia-Pacific, driven by high paced growth from emerging markets such as China and India constitutes the largest regional market, as stated by Global Industry Analysts's research report on Industrial
Global Industry Analysts, Inc., July 2010, Pages: 293
such as Alliance Boots, China National Pharmaceutical Group Corporation, China Nepstar Chain Drugstore Ltd., CVS Caremark Corporation, Discount Drug Mart, Inc., Health Mart Systems, Inc., Hunan LaoBaiXing Retail
Global Industry Analysts, Inc., Jan 2012, Pages: 386
, China, India, South Korea, Argentina, Brazil, and Mexico among others. The report offers a compilation of all recent mergers, acquisitions and strategic corporate developments in addition to an included
Axis Research Mind, Nov 2011, Pages: 342
.
Report Focus:
The report “Polymerase Chain Reaction (PCR): Products/Tools – A Global Market Watch, 2009-2015” reviews the latest PCR market trends with a perceptive attempt to disclose the near-future
Markets and Markets, April 2010, Pages: 118
market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps
Global Industry Analysts, Inc., April 2011, Pages: 402
-Pharmaceuticals represents the largest sector in the Indian biotechnology industry, as stated by the new Global Industry Analysts' market research report on Biotechnology In India. Bio-Services trails behind Bio
Business Monitor International, Nov 2008, Pages: 104
ChinaPharmaceuticals and Healthcare Report Q4 2008 BMI's ChinaPharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on China's pharmaceuticals
Koncept Analytics, Nov 2010, Pages: 36
. Opportunities
5.1 Burgeoning Indian and Chinese Market
5.2 Monoclonal Antibodies- Fastest Growing segment
6. Market Outlook
7. Major Players
7.1 Teva PharmaceuticalsIndustries Ltd.
7.1.1 Business
Research In China, April 2007, Pages: 165
China Packaging IndustryReport, 2006 China modern packaging industry develops rapidly after the implementation of reform and opening policy. With the development of domestic trades, especially
Research In China, March 2007, Pages: 50
as well as the related enterprises & organizations.
Please note this report is currently only available in Chinese. However, if you wish to obtain an English version, a translation service is available
Axis Research Mind, Nov 2011, Pages: 615
, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
35. BIOREPOSITORIES - END-USERS - PHARMACEUTICALS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD
Global Industry Analysts, Inc., April 2011, Pages: 212
in China is forecast to accelerate expansion rate to a robust CAGR of 5.5% through 2017.
Key participants profiled in the report include AIDP, Inc., Ajinomoto AminoScience, LLC, Alfa Aesar, Biosynth AG
Global Industry Analysts, Inc., Feb 2011, Pages: 324
for
Pharmaceuticals, and Agrochemicals Markets for Years 2005,
2010 & 2015 103
19. REST OF WORLD 104
A.Market Analysis 104
Outlook 104
India 104
Chiral Drugs in the Indian Market 104
China-A Hub
Global Industry Analysts, Inc., July 2009, Pages: 1810
III-133
China III-133
Chinese Pharma Industry Remains Immune to Global Crisis,
for Now III-134
Issues and Trends III-134
Pharmaceutical Firms to Play Pivotal Role in Transforming
Healthcare System III
